Verici Dx plc (LON:VRCI – Get Free Report)’s stock price was down 12.9% on Thursday . The stock traded as low as GBX 2.53 ($0.03) and last traded at GBX 2.53 ($0.03). 325,413 shares changed hands during mid-day trading, a decline of 70% from the average daily volume of 1,098,470 shares. The stock had previously closed at GBX 2.90 ($0.04).
Verici Dx Stock Performance
The business’s fifty day moving average is GBX 3.03 and its 200-day moving average is GBX 3.75. The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.64. The company has a market cap of £9.56 million, a PE ratio of -1.82 and a beta of 1.59.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
See Also
- Five stocks we like better than Verici Dx
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Industrial Products Stocks Investing
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
